Opus Genetics (IRD) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -44.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.67% |
| Dec 31, 2025 | 69.88% |
| Sep 30, 2025 | -3.77% |
| Jun 30, 2025 | -6.94% |
| Mar 31, 2025 | -28.81% |
| Dec 31, 2024 | -600.48% |
| Sep 30, 2024 | -225.41% |
| Jun 30, 2024 | -54.54% |
| Mar 31, 2024 | -25.72% |
| Dec 31, 2023 | -115.87% |
| Sep 30, 2023 | 240.72% |
| Jun 30, 2023 | -9.13% |
| Mar 31, 2023 | 5.79% |
| Dec 31, 2022 | 656.26% |
| Sep 30, 2022 | -7.23% |
| Jun 30, 2022 | 30.81% |
| Mar 31, 2022 | -25.49% |
| Dec 31, 2021 | 56.14% |
| Sep 30, 2021 | -117.25% |
| Jun 30, 2021 | -465.53% |
| Mar 31, 2021 | -89.62% |
| Dec 31, 2020 | -379.69% |
| Sep 30, 2020 | 14.58% |
| Jun 30, 2020 | 57.77% |
| Mar 31, 2020 | 30.54% |
| Dec 31, 2019 | 200.95% |
| Sep 30, 2019 | 51.31% |
| Jun 30, 2019 | 40.25% |
| Mar 31, 2019 | 33.10% |
| Dec 31, 2018 | -1.39% |
| Sep 30, 2018 | -11.01% |
| Jun 30, 2018 | -16.75% |
| Mar 31, 2018 | -48.89% |
| Dec 31, 2017 | -24.99% |
| Sep 30, 2017 | -13.50% |
| Jun 30, 2017 | -9.49% |
| Mar 31, 2017 | 18.72% |
| Dec 31, 2016 | 10.26% |
| Sep 30, 2016 | 20.20% |
| Jun 30, 2016 | 18.82% |
| Mar 31, 2016 | -10.10% |
| Dec 31, 2015 | -13.36% |
| Sep 30, 2015 | -48.28% |
| Jun 30, 2015 | -37.36% |
| Mar 31, 2015 | -59.71% |
| Dec 31, 2014 | -65.17% |
| Sep 30, 2014 | -72.25% |
| Jun 30, 2014 | -83.38% |
| Mar 31, 2014 | -44.90% |
| Dec 31, 2013 | -122.85% |
| Sep 30, 2013 | -1.34% |
| Jun 30, 2013 | -3.49% |
| Mar 31, 2013 | -1.32% |
| Dec 31, 2012 | 56.46% |
| Sep 30, 2012 | 46.36% |
| Jun 30, 2012 | 71.37% |
| Mar 31, 2012 | 51.85% |
| Dec 31, 2011 | 23.83% |
| Sep 30, 2011 | -41.71% |
| Jun 30, 2011 | -102.53% |